Principles of Anti-infective Dosing in Pregnancy

Andrade, 2004, Prescription drug use in pregnancy, Am J Obstet Gynecol, 191, 398, 10.1016/j.ajog.2004.04.025 Mitchell, 2011, National Birth Defects Prevention Study. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008, Am J Obstet Gynecol, 205, e1 Patil, 2003, Health care providers’ use of a drug information service for pregnancy-related inquiries, J Am Pharm Assoc, 2014, 502 Chen, 2000, Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics, Clin Pharmacol Ther, 68, 510, 10.1067/mcp.2000.111184 Lalonde, 2011, Drugs indicated for use during pregnancy, J Popul Ther Clin Pharmacol, 18, e513 2014, Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule, Fed Regist, 79, 72063 Costantine, 2014, Physiologic and pharmacokinetic changes in pregnancy, Frontiers Pharmacol, 5, 65, 10.3389/fphar.2014.00065 Cunningham, 2013, Maternal physiology Robson, 1990, Apparent liver blood flow during pregnancy: a serial study using indocyanine green clearance, Br J Obstet Gynaecol, 97, 720, 10.1111/j.1471-0528.1990.tb16246.x Creasy, 2009 Frederiksen, 1986, Theophylline pharmacokinetics in pregnancy, Clin Pharmacol Ther, 40, 321, 10.1038/clpt.1986.183 Chang, 2012, Physiologic adaptations to pregnancy, Neurol Clin, 30, 781, 10.1016/j.ncl.2012.05.001 2011, ACOG Practice Bulletin No. 120: Use of prophylactic antibiotics in labor and delivery, Obstet Gynecol, 117, 1472, 10.1097/AOG.0b013e3182238c31 Smaill, 2010, Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section, Cochrane Database Syst Rev, CD007482 Currier, 1993, Cefazolin compared with cefoxitin for cesarean section prophylaxis: the use of a two-stage study design, J Clin Epidemiol, 46, 625, 10.1016/0895-4356(93)90035-Y Faro, 1990, Antibiotic prophylaxis: is there a difference?, Am J Obstet Gynecol, 162, 900, 10.1016/0002-9378(90)91290-S Pai, 2007, Antimicrobial dosing considerations in obese adult patients, Pharmacotherapy, 27, 1081, 10.1592/phco.27.8.1081 Elkomy, 2014, Pharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery, Antimicrob Agents Chemother, 58, 3504, 10.1128/AAC.02613-13 Pevzner, 2011, Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery, Obstet Gynecol, 117, 877, 10.1097/AOG.0b013e31820b95e4 Swank, 2015, Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women, Am J Obstet Gynecol, 213, e1 Stitely, 2013, Plasma and tissue cefazolin concentrations in obese patients undergoing cesarean delivery and receiving differing pre-operative doses of drug, Surg Infect (Larchmt), 14, 455, 10.1089/sur.2012.040 Maggio, 2015, Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial, Obstet Gynecol, 125, 1205, 10.1097/AOG.0000000000000789 Ahmadzia, 2015, Obstetric surgical site infections: 2 grams compared with 3 grams of cefazolin in morbidly obese women, Obstet Gynecol, 126, 708, 10.1097/AOG.0000000000001064 Ward, 2016, A comparison of 3 antibiotic regimens for prevention of postcesarean endometritis: an historical cohort study, Am J Obstet Gynecol, 214, e1 Sutton, 2015, Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis, Am J Obstet Gynecol, 212, e1 Maertens, 2016, Pertussis vaccination during pregnancy in Belgium: results of prospective controlled cohort study, Vaccine, 34, 142, 10.1016/j.vaccine.2015.10.100 Benowitz, 2010, Influenza vaccine given to pregnant women reduces hospitalizations due to influenza in their infants, Clin Infect Dis, 51, 1355, 10.1086/657309 Lindsey, 2013, Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants, Curr Opin Infect Dis, 26, 248, 10.1097/QCO.0b013e3283607a58 Swamy, 2014, Maternal immunization to benefit the mother, fetus, and infant, Obstet Gynecol Clin North Am, 41, 521, 10.1016/j.ogc.2014.08.001 Swamy, 2015, Vaccinations for pregnant women, Obstet Gynecol, 125, 212, 10.1097/AOG.0000000000000581 Sukumaran, 2015, Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy, Obstet Gynecol, 126, 1069, 10.1097/AOG.0000000000001066 Swamy, 2015, Maternal benefits of immunization during pregnancy, Vaccine, 33, 6436, 10.1016/j.vaccine.2015.08.035 Zaman, 2008, Effectiveness of maternal influenza immunization in mothers and infants, N Engl J Med, 359, 1555, 10.1056/NEJMoa0708630 Doyle, 2013, Maternal and neonatal outcomes among pregnant women with 2009 pandemic influenza A(H1N1) Illness in Florida, 2009-2010: A population-based cohort study, PLoS One, 8, e79040, 10.1371/journal.pone.0079040 Committee on Obstetric Practice and Immunization Expert Work Group; Centers for Disease Control and Prevention’s Advisory Committee on Immunization, United States; American College of Obstetricians and Gynecologists. Committee opinion no. 608: influenza vaccination during pregnancy. Obstet Gynecol. 2014;124:648-51. Donaldson, 2015, What determines uptake of pertussis in vaccine in pregnancy? A cross sectional survey in an ethnically diverse population of pregnant women in London, Vaccine, 33, 5822, 10.1016/j.vaccine.2015.08.093 Walls, 2016, Infant outcomes after exposure to Tdap vaccine in pregnant: an observational study, BMJ Open, 6, e009356, 10.1136/bmjopen-2015-009536 Kim, 2015, Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance, Am J Obstet Gynecol, 213, S29, 10.1016/j.ajog.2015.08.040 Gabbe, 2002 Gibbs, 1988, A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection, Obstet Gynecol, 72, 823, 10.1097/00006250-198812000-00001 Gilstrap, 1988, Antibiotic concentration in maternal blood, cord blood, and placental membranes in chorioamnionitis, Obstet Gynecol, 72, 124 Maberry, 1991, Anaerobic coverage for intra-amniotic infection: maternal and perinatal impact, Am J Perinatol, 8, 338, 10.1055/s-2007-999409 Locksmith, 2005, High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels, Obstet Gynecol, 105, 473, 10.1097/01.AOG.0000151106.87930.1a Dotters-Katz, 2016, Risk factors for post-operative wound infection in the setting of chorioamnionitis and cesarean delivery, J Matern Fetal Neonatal Med, 29, 1541, 10.3109/14767058.2015.1058773 Brown, 2012, Ertapenem compared to combination drug therapy for the treatment of postpartum endometritis after cesarean delivery, J Matern Fetal Neonatal Med, 25, 743, 10.3109/14767058.2011.594117 Quinney, 2014, Is personalized medicine achievable in obstetrics?, Semin Perinatol, 38, 534, 10.1053/j.semperi.2014.08.017